Skip to main content

Genetics Startups

Updated July 2026

Companies in the genetics sector developing innovative solutions and technologies.

Explore 307 recently funded genetics companies with verified founder contact information and fundraising data.

Total Companies
307
Total Funding
$773.0M
Avg Funding
$30.9M
Global Reach
7
countries

Top Cities for Genetics

Boston
South San Francisco
San Francisco
Menlo Park
Dresden
Richmond

Recently Funded Companies

Export
Boston, United States

Kelonia Therapeutics develops genetic medicines focused on in vivo gene delivery and cell therapy for cancer and other diseases.

$50.0M raised
Apr 2022

Founder Contacts

30,000+ verified contacts

South San Francisco, United States

Chimera solves the challenges of CARs with drug-responsive gene regulators, which allow us to re-program of the immune system.

$7.5M raised
Apr 2022

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Mammoth Biosciences develops novel CRISPR applications for disease detection, research, agriculture, biodefense, and more.

$95.0M raised
Apr 2024

Founder Contacts

30,000+ verified contacts

Menlo Park, United States

Deepcell is a life science company specializing in AI-powered single-cell classification and isolation for basic and translational research.

Apr 2025

Founder Contacts

30,000+ verified contacts

Dresden, Germany

Seamless Therapeutics is reshaping the gene editing paradigm with a novel approach to restoring health in patients.

$12.6M raised
Apr 2024

Founder Contacts

30,000+ verified contacts

South San Francisco, United States

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

Apr 2026

Founder Contacts

30,000+ verified contacts

Richmond, Australia

Eugene apps make it easy to order genetic tests, connect with counselors, get referrals, & see all reports in one place.

Apr 2025

Founder Contacts

30,000+ verified contacts

Montreal, Canada

Simmunome is an artificial intelligence-based contract research organization.

Apr 2025

Founder Contacts

30,000+ verified contacts

Brisbane, United States

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

Apr 2026

Founder Contacts

30,000+ verified contacts

San Diego, United States

Center for Aquaculture Technologies is a research and development company using all modern genetic improvement technologies.

$7.0M raised
Apr 2023

Founder Contacts

30,000+ verified contacts

Eugene, United States

InVivo Biosystems specializes in genome editing and preclinical research for neurological, metabolic, and rare monogenic diseases.

Apr 2025

Founder Contacts

30,000+ verified contacts

Los Angeles, United States

Minicircle develops a human genetic enhancement platform to facilitate life extension capabilities.

$459K raised
Apr 2024

Founder Contacts

30,000+ verified contacts

San Diego, United States

Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform.

$28.0M raised
Apr 2023

Founder Contacts

30,000+ verified contacts

South San Francisco, United States

Tacit Therapeutics created RNA-targeting treatments for devastating diseases.

$19.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Cambridge, United States

QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.

$88.0M raised
Mar 2023

Founder Contacts

30,000+ verified contacts

Brooklyn, United States

Girihlet is a provider of rapid and accurate deep sequencing services with a unique focus on developing novel technologies.

$500K raised
Mar 2022

Founder Contacts

30,000+ verified contacts

San Francisco, United States

DNALite Therapeutics is an early-stage preclinical biotechnology company.

Mar 2023

Founder Contacts

30,000+ verified contacts

Charlestown, United States

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

$240.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Sydney, Australia

Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more accessible genomics data.

$317K raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Natick, United States

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

$182.0M raised
Mar 2024

Founder Contacts

30,000+ verified contacts

Paris, France

Enabling tomorrow's therapies manufacturing for today's patients, with sound

$2.8M raised
Mar 2023

Founder Contacts

30,000+ verified contacts

London, United Kingdom

Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.

$34.0M raised
Mar 2023

Founder Contacts

30,000+ verified contacts

Lausanne, Switzerland

Alithea Genomics develops molecular biology tools and sequencing-based solutions for large-scale gene expression analysis.

$3.8M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Seattle, United States

Phase Genomics develops a biotechnology platform for new discoveries in agriculture, human health, and industrial biology industries.

$1.5M raised
Mar 2024

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Fortuna is a biotechnology company that provides forecasting and screening technology solutions for non-invasive embryo trait assessment.

$500K raised
Mar 2022

Founder Contacts

30,000+ verified contacts

Showing 101 to 125 of 307 companies

About the Genetics Startup Ecosystem

The genetics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Genetics

Genetics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The genetics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Genetics Funding Breakdown

Here is how funding is distributed among the 307 genetics companies tracked in the VCBacked database.

Average Funding
$30.9M
Total Funding Tracked
$773.0M
Countries Represented
7

Distribution by Funding Stage

Other25 companies

Top Cities for Genetics

1.South San Francisco
3 companies$26.5M
2.San Francisco
2 companies$95.0M
3.San Diego
2 companies$35.0M
4.Cambridge
2 companies$88.5M
5.Boston
1 companies$50.0M

Related Industries

Companies in the genetics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Genetics Startups?

Perfect for: B2B sales teams targeting genetics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked